Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133435) titled 'Effects of Early PCSK9 Inhibitor Therapy on Inflammatory Response and Related Adipokines in Patients with Acute Myocardial Infarction' on Sept. 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Liuzhou Worker's Hospital
Condition:
Acute myocardial infarction
Intervention:
Control Group:Standard Treatment
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-30
Target Sample Size: Control Group:60;PCSK9 inhibitor intervention group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335592
Published...